Latest Market Access News

BPH Global reported a seasonal dip in December revenue due to rainy conditions affecting seaweed supply, yet maintains strong growth momentum with A$1.77 million gross revenue over seven months.

Memphasys Limited has completed a $579K shortfall placement, boosting total funds raised to over $1.12 million to support the commercial rollout of its Felix™ System following recent regulatory approvals.

Kinetiko Energy has secured approval to trade on the North American OTCQB Market, aiming to boost investor access and liquidity as it advances its South African gas projects.

Fenix Resources’ latest Scoping Study outlines a robust plan to ramp up Weld Range iron ore production to 10 million tonnes per annum by 2031, extending mine life to 2042 with significantly reduced costs and strong financial returns.

Central Petroleum has secured strategic interests in the Cooper and Otway Basins through binding agreements with ADX Energy, setting the stage for a multi-million dollar expansion and planned drilling campaigns in 2026 and 2027.

Blue Star Helium has successfully started helium production at its Galactica project in Colorado, positioning itself as America’s newest helium producer with sales targeted for early 2026. The company’s strategic joint venture and low-cost operations underpin a promising growth trajectory amid rising helium and CO₂ demand.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.

WRKR Limited has agreed to acquire PaidRight, a leading payroll compliance platform, in a strategic move to expand beyond superannuation compliance. The deal, valued at approximately A$11.4 million, aims to integrate advanced real-time payroll compliance technology into WRKR’s platform.

HyTerra Limited has unveiled a comprehensive Strategic Plan targeting commercialisation of its Kansas hydrogen project and ambitious expansion across the US and globally. The plan leverages proprietary technology and recent drilling successes to position the company at the forefront of the emerging geologic hydrogen sector.

Orthocell has reached a significant milestone with 100 units of its nerve repair product Remplir™ sold in the US, signaling accelerating adoption in a $1.6 billion market. The company’s strategic medical education and distributor network are driving momentum ahead of further hospital approvals.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Emperor Energy appoints Tim Handley as Managing Director to spearhead the Judith Gas Field's next phase, including the critical Judith-2 appraisal well planned for Q3 2026.